Search
Menu
Deposition Sciences Inc. - Difficult Coatings - LB - 8/23

FDA Nixes Heart-Surgery Device

Facebook X LinkedIn Email
A US Food and Drug Administration panel has rejected by a vote of 9-2 the use of a device to treat end-stage heart disease. The procedure, known as transmyocardial revascularization, involves piercing holes in the heart wall with a laser. The proposed laser system, from PLC Systems Inc. of Franklin, Mass., is designed as an option to chronic chest pain sufferers who do not respond to angioplasty or coronary artery bypass surgery. FDA panelists criticized the company for incomplete trial data and for its limited understanding of how the laser procedure restores blood flow to damaged heart...Read full article

Related content from Photonics Media



    Articles


    Webinars


    Photonics Dictionary Terms


    Media
    Published: September 1997
    Businesslight speed

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.